NLRP6 and metabolic dysfunction-associated steatotic liver disease: Besides, a previous study with NAFLD obese patients demonstrates that when hepatic portal fibrosis is present, the expression of NLRP6 mRNA in adipose tissues is higher compared to cases when hepatic portal fibrosis is not observed (21).